Clinical Report on Arthramid Vet Vol 1, Issue 2. Nov, 2020 Dr Jason Lowe BVSc, Cert EP In this second issue we report on how an experienced racetrack veterinarian managed a case of chronic tenosynovitis of the deep digital flexor tendon sheath in a racing Thoroughbred...
Clinical comment: Treatment of subchondral bone disease in the equine fetlock joint Clinical Report on Arthramid Vet. Vol 1, Issue 1. Oct, 2020 Dr Jason Lowe BVSc, CertEP. We recently met with experienced racetrack veterinarians’ that have introduced Arthramid Vet...
Pioneering treatment for arthritis may improve equine welfare and reduce wastage Dr Jason Lowe BVSc, Cert EP, Cambridge, New Zealand – 29 July 2020 Equine veterinarians have a range of options to treat lameness in horses caused by osteoarthritis (OA) and practitioners...
Arthrosamid 2.5% PAAG- The Human Equivalent Arthrosamid is the 2.5% polyacrylamide hydrogel developed as a long-acting intra-articular injection for the treatment of osteoarthritis in humans.Development of Arthrosamid commenced after the generation of impressive...
Use of Arthramid Vet in Canine Intra-articular injections Nupsala Learning Resources in the UK recently published this webinar on Canine Intra-articular Injection. Dr Karen Cook BA VetMB BSc (Hons) MRCVS presents an informative webinar on the injection technique for...
2.5% PAAG for managing intercarpal joint lameness in horses- AAEP Presentation 2019 Dr Leigh de Clifford BVSc CertAVP PGDipVPS MSc MRCVS Article posted by Nancy S Loving DVM, in Equi Management. 30 Mar, 2020. This was a presentation at the 2019 AAEP Convention that...
Recent Comments